@misc{misc75947448,
title   = {In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials.”. [Carta]},
author = {Arruda, Gustavo Viani and Gouveia, Andre G. and Moraes, Fabio Y.},
year = {2022},
doi = {10.1016/j.radonc.2022.09.017},
journal   = {Radiotherapy and Oncology}
}